End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.46 CNY | -0.97% | +0.10% | -17.70% |
May. 13 | Humanwell Healthcare's Unit Gets Nod to Strengthen Oxycodone Hydrochloride Tablets' Dosage | MT |
Apr. 30 | Humanwell Healthcare's Q1 Profit Falls 27% | MT |
Business Summary
Number of employees: 17,676
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
99.4
%
| 22,201 | 99.4 % | 24,385 | 99.4 % | +9.84% |
Environmental
0.6
%
| 137 | 0.6 % | 140 | 0.6 % | +2.40% |
Intersegment Elimination
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | +8.45% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
89.0
%
| 19,721 | 88.5 % | 21,746 | 89.0 % | +10.27% |
Foreign
11.0
%
| 2,555 | 11.5 % | 2,699 | 11.0 % | +5.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jie Li
CHM | Chairman | 69 | 03-04-30 |
Xia Fei Deng
PSD | President | 61 | 98-02-28 |
Ya Jun Wu
DFI | Director of Finance/CFO | 54 | 05-03-27 |
Xue Hai Wang
BRD | Director/Board Member | 50 | 03-01-31 |
Wen Jing Wu
IRC | Investor Relations Contact | - | - |
Qian Lun Li
SEC | Corporate Secretary | 45 | 13-05-06 |
Wen Tao Du
PRN | Corporate Officer/Principal | 57 | 03-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rui Zhou
BRD | Director/Board Member | 51 | 21-05-27 |
Xiao Dong Zhang
BRD | Director/Board Member | 73 | 05-03-27 |
Xia Fei Deng
PSD | President | 61 | 98-02-28 |
Lin Qing Liu
BRD | Director/Board Member | 50 | 09-09-10 |
Xue Hai Wang
BRD | Director/Board Member | 50 | 03-01-31 |
Jie Li
CHM | Chairman | 69 | 03-04-30 |
Hao He
BRD | Director/Board Member | 37 | 11-04-30 |
Jian min Zhu
BRD | Director/Board Member | 44 | 15-03-31 |
Han Sheng Zhou
BRD | Director/Board Member | 35 | 17-04-19 |
Su Hua Zhang
BRD | Director/Board Member | 48 | 22-05-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,632,361,067 | 998,999,385 ( 61.20 %) | 873,360 ( 0.0535 %) | 61.20 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
23,539,035 | 1.62% | 65,824,087 $ | |
132,210,237 | 1.53% | 53,311,134 $ |
Company contact information
Humanwell Healthcare (Group) Co., Ltd.
No. 666 Gaoxin Avenue East Lake High-tech Development Zone
430075, Wuhan
+
http://www.humanwell.com.cnSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.70% | 4.6B | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- 600079 Stock
- Company Humanwell Healthcare (Group) Co.,Ltd.